SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Kizzmekia S. Corbett(Harvard University), Tracy J. Ruckwardt(National Institutes of Health), Christine A. Shaw(Moderna Therapeutics (United States)), Guillaume B. E. Stewart-Jones(Moderna Therapeutics (United States)), Cynthia T. Ziwawo(National Institutes of Health), David R. Martinez(University of North Carolina at Chapel Hill), Rebecca J. Loomis(GlaxoSmithKline (India)), Kendra L. Gully(University of North Carolina at Chapel Hill), Stephen D. Schmidt(Philips (United States)), Ethan J. Fritch(Public Health Dayton & Montgomery County), Sunny Himansu(Moderna Therapeutics (United States)), Wing‐Pui Kong(National Institute of Allergy and Infectious Diseases), Eun Sung Yang(National Institutes of Health), Daniel Wrapp(Duke University), Nedim Emil Altaras(Moderna Therapeutics (United States)), Lingshu Wang(National Institutes of Health), Mahnaz Minai(National Institutes of Health), Geoffrey B. Hutchinson(National Institutes of Health), Sarah R. Leist(University of North Carolina at Chapel Hill), Martha Nason(National Institutes of Health), Sayda M. Elbashir(Max Planck Institute for Biophysical Chemistry), Seyhan Boyoglu-Barnum(National Institutes of Health), LingZhi Ma(Moderna Therapeutics (United States)), Kwanyee Leung(National Institutes of Health), Angela Woods(Moderna Therapeutics (United States)), Mark K. Louder(Henry M. Jackson Foundation), Laura J. Stevens(Vanderbilt University Medical Center), Vladimir Presnyak(Moderna Therapeutics (United States)), Anthony DiPiazza(Moderna Therapeutics (United States)), Hamilton Bennett(Moderna Therapeutics (United States)), Elisabeth Narayanan(Moderna Therapeutics (United States)), Isabella Renzi(Moderna Therapeutics (United States)), Lauren A. Chang(Icahn School of Medicine at Mount Sinai), Olubukola M. Abiona(National Institutes of Health), Kapil Bahl(Moderna Therapeutics (United States)), Kenneth H. Dinnon(University of North Carolina at Chapel Hill), Dario Garcia-Dominguez(McGovern Institute for Brain Research), Rebecca A. Gillespie(National Institutes of Health), Darin K. Edwards(Moderna Therapeutics (United States)), Bianca M. Nagata(National Institutes of Health), Nianshuang Wang(The University of Texas at Austin), Wei Shi(National Institutes of Health), Nicole A. Doria‐Rose(National Institutes of Health), Ande West(University of North Carolina at Chapel Hill), Kevin W. Bock(National Institute of Allergy and Infectious Diseases), Yi Zhang(National Institutes of Health), Catherine Liu(University of California, San Francisco), Mihir Metkar(Moderna Therapeutics (United States)), Alexandra Schäfer, Emily Phung(National Institutes of Health)
Cited by 143
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k